Neurosteroid allopregnanolone attenuates cognitive dysfunctions in 6-OHDA-induced rat model of Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Behavioural Brain Research

• Publication date

  2016-05-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.bbr.2016.03.019PMID 26970579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of castration on the susceptibility of male rats to the sleep deprivation-induced impairment of behavioral and synaptic plasticity.

  2015cited by this paper
• Alterations in primary motor cortex neurotransmission and gene expression in hemi-parkinsonian rats with drug-induced dyskinesia.

  2015cited by this paper
• Intranigral lipopolysaccharide induced anxiety and depression by altered BDNF mRNA expression in rat hippocampus.

  2014cited by this paper
• Investigation on Alternative Treatment Approaches in the Unilateral 6-OHDA Lesion Rat Model of Parkinson's Disease

  2014cited by this paper
• GDNF, NGF and BDNF as therapeutic options for neurodegeneration.

  2013cited by this paper
• Allopregnanolone Reinstates Tyrosine Hydroxylase Immunoreactive Neurons and Motor Performance in an MPTP-Lesioned Mouse Model of Parkinson's Disease

  2012cited by this paper
• Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice.

  2012cited by this paper
• Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease.

  2012cited by this paper
• BMSC and CoQ10 improve behavioural recovery and histological outcome in rat model of Parkinson's disease.

  2011cited by this paper
• Chronic progesterone treatment of male rats with unilateral 6-hydroxydopamine lesion of the dorsal striatum exacerbates [corrected] parkinsonian symptoms.

  2011cited by this paper
• Cognitive-Enhancing Effect of Quercetin in a Rat Model of Parkinson's Disease Induced by 6-Hydroxydopamine

  2011cited by this paper
• Neurosteroid Biosynthetic Pathway Changes in Substantia Nigra and Caudate Nucleus in Parkinson's Disease

  2010cited by this paper
• The role of medial temporal lobe in retrieving spatial and nonspatial relations from episodic and semantic memory

  2009cited by this paper
• The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease

  2009cited by this paper
• Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats.

  2009cited by this paper
• Hydroxydopamine lesions enhance progesterone-facilitated lordosis of rats and hamsters , independent of effects on motor behavior

  2009cited by this paper
• Neurosteroids as modulators of neurogenesis and neuronal survival.

  2008cited by this paper
• Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats.

  2008cited by this paper
• 7-nitroindazole attenuates 6-hydroxydopamine-induced spatial learning deficits and dopamine neuron loss in a presymptomatic animal model of Parkinson's disease.

  2008cited by this paper
• Regenerative potential of allopregnanolone.

  2008cited by this paper
• Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion

  2007cited by this paper
• Cognitive impairment in patients with Parkinson’s disease: profiles and implications for prognosis

  2007cited by this paper
• Perinatal allopregnanolone influences prefrontal cortex structure, connectivity and behavior in adult rats.

  2006cited by this paper
• Sex and ovarian steroids modulate brain-derived neurotrophic factor (BDNF) protein levels in rat hippocampus under stressful and non-stressful conditions.

  2006cited by this paper
• The Neurosteroids Progesterone and Allopregnanolone Reduce Cell Death, Gliosis, and Functional Deficits after Traumatic Brain Injury in Rats

  2005cited by this paper
• Effect of Psychiatric and Other Nonmotor Symptoms on Disability in Parkinson's Disease

  2004cited by this paper
• Are men at greater risk for Parkinson’s disease than women?

  2004cited by this paper
• Developing neurons make the switch

  2004cited by this paper
• Developing neurons make the switch

  2004cited by this paper
• Niemann–Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone

  2004cited by this paper
• Decreased plasma and cerebrospinal fluid content of neuroactive steroids in Parkinson’s disease

  2003cited by this paper
• Direct economic impact of Parkinson's disease: A research survey in the United Kingdom

  2003cited by this paper
• Parkinson's Disease Mechanisms and Models

  2003cited by this paper
• Progesterone protects against necrotic damage and behavioral abnormalities caused by traumatic brain injury.

  2002cited by this paper
• The Lesion of the Rat Substantia Nigra pars compacta Dopaminergic Neurons as a Model for Parkinson's Disease Memory Disabilities

  2002cited by this paper
• Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.

  2002cited by this paper
• Cognitive Impairment of Rats Caused by Oxidative Stress and Aging, and Its Prevention by Vitamin E

  2002cited by this paper
• Is there more to gaba than synaptic inhibition?

  2002cited by this paper
• Applications of the Morris water maze in the study of learning and memory.

  2001cited by this paper
• Neurosteroids and brain function

  2001cited by this paper
• Neuroprotective properties of 17β‐estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice

  2001cited by this paper
• The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease.

  2001cited by this paper
• Mice are not little rats: species differences in a one‐day water maze task

  2000cited by this paper
• Electrophysiology of dopamine in normal and denervated striatal neurons.

  2000cited by this paper
• Stress and hippocampal plasticity.

  1999cited by this paper
• Prevention of 6-hydroxydopamine-induced rotational behavior by BDNF somatic gene transfer.

  1999cited by this paper
• Treatment with estrogen and progesterone affects relative levels of brain-derived neurotrophic factor mRNA and protein in different regions of the adult rat brain.

  1999cited by this paper
• The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats.

  1995cited by this paper
• BDNF attenuates the effects of intrastriatal injection of 6‐hydroxydopamine

  1995cited by this paper
• The epidemiology of Parkinson's disease in the county of Rogaland, Norway

  1995cited by this paper
• Transforming growth factor β1 expression in the endometrium of the mare during placentation

  1995cited by this paper
• Insulin-like growth factor II gene expression in the fetus and placenta of the horse during the first half of gestation.

  1995cited by this paper
• Gender influences outcome of brain injury: progesterone plays a protective role.

  1993cited by this paper
• Parkinson's disease mortality and the industrial use of heavy metals in Michigan

  1993cited by this paper
• The genetics of Parkinson's disease. A review.

  1993cited by this paper
• Ageing and Parkinson's disease: substantia nigra regional selectivity.

  1991cited by this paper
• The effects of 6-OHDA-induced dopamine depletions in the ventral or dorsal striatum on maternal and sexual behavior in the female rat.

  1991cited by this paper
• A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data.

  1988cited by this paper
• The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat.

  1982cited by this paper

• Neurofilament light chain protein exposure contributes to protein aggregation, microgliosis, astrogliosis and neuroinflammation via p38/MK2/NF-κB/CREB1/Nrf2/HO-1 signalling leading to Parkinson's disease.

  2026cites this paper
• Computational modeling of resistance to hormone-mediated remission in childhood absence epilepsy

  2026cites this paper
• Multi-omics characterization of improved cognitive functions in Parkinson’s disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial

  2025cites this paper
• Activation or blockade of prelimbic 5-HT4 receptors improves working memory in hemiparkinsonian rats.

  2025cites this paper
• Synthesis of a New Bioconjugate Steroid Pyridinium Salt Derived from Allopregnanolone Acetate

  2025cites this paper
• Expanding the therapeutic potential of neuro(active)steroids: a promising strategy for hyperdopaminergic behavioral phenotypes.

  2024cites this paper
• Neuroactive Steroids, Toll-like Receptors, and Neuroimmune Regulation: Insights into Their Impact on Neuropsychiatric Disorders

  2024cites this paper
• Allopregnanolone And Its Antagonist Modulate Neuroinflammation And Neurological Impairment.

  2024cites this paper
• Impact of NMDA receptors block versus GABA-A receptors modulation on synaptic plasticity and brain electrical activity in metabolic syndrome.

  2024cites this paper
• Neurosteroids and their potential as a safer class of general anesthetics

  2024cites this paper
• The Role of Inhaled Estradiol and Myrtenol, Alone and in Combination, in Modulating Behavioral and Functional Outcomes Following Traumatic Experimental Brain Injury: Hemodynamic, Molecular, Histological and Behavioral Study

  2023cites this paper
• Zuranolone – synthetic neurosteroid in treatment of mental disorders: narrative review

  2023cites this paper
• A comprehensive and updated review on the applications of vesicular drug delivery systems in treatment of brain disorders: A shelter against storms

  2023cites this paper
• Endurance exercise training attenuates the waterpipe smoke inhaling-induced learning and memory impairment in Rats: Role of neurotrophic factors and apoptotic system.

  2023cites this paper
• Disease stage-dependent changes in brain levels and neuroprotective effects of neuroactive steroids in Parkinson's disease.

  2023cites this paper
• Task-specific effects of biological sex and sex hormones on object recognition memories in a 6-hydroxydopamine-lesion model of Parkinson’s disease in adult male and female rats

  2022cites this paper
• Progestogen-Mediated Neuroprotection in Central Nervous System Disorders

  2022cites this paper
• The effects of neurosteroid allopregnanolone on synaptic dysfunction in the hippocampus in experimental parkinsonism rats: An electrophysiological and molecular study.

  2022cites this paper
• A Potential Mechanism Underlying the Therapeutic Effects of Progesterone and Allopregnanolone on Ketamine-Induced Cognitive Deficits

  2021cites this paper
• Role of IGF-1 in neuroinflammation and cognition deficits induced by sleep deprivation.

  2021cites this paper
• Allopregnanolone: An overview on its synthesis and effects

  2021cites this paper
• Combined Metabolic Activators Improve Cognitive Functions without Altering Motor Scores in Parkinson's Disease

  2021cites this paper
• Fluoxetine tunes the abnormal hippocampal oscillations in association with cognitive impairments in 6-OHDA lesioned rats.

  2021cites this paper
• Microglial Cell Morphology and Phagocytic Activity Are Critically Regulated by the Neurosteroid Allopregnanolone: A Possible Role in Neuroprotection

  2021cites this paper
• Study on the Regulation Effect of Optogenetic Technology on LFP of the Basal Ganglia Nucleus in Rotenone-Treated Rats

  2021cites this paper
• Apelin-13 prevents hippocampal synaptic plasticity impairment in Parkinsonism rats.

  2020cites this paper
• Early transcranial direct current stimulation treatment exerts neuroprotective effects on 6-OHDA-induced Parkinsonism in rats.

  2020cites this paper
• Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease

  2020cites this paper
• Physiopathological role of the enzymatic complex 5α-reductase and 3α/β- hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites.

  2020cites this paper
• Progesterone in the Brain: Hormone, Neurosteroid and Neuroprotectant

  2020cites this paper
• Neuroprotective and Antiapoptotic Effects of Allopregnanolone and Curcumin on Arsenic-Induced Toxicity in SH-SY5Y Dopaminergic Human Neuroblastoma Cells

  2020cites this paper
• Enhancing Spatial Memory Effects of Black Seed, Frankincense, and Ginger Extracts Using Albino Mice

  2020cites this paper
• Voluntary exercise modulates learning & memory and synaptic plasticity impairments in sleep deprived female rats.

  2019cites this paper
• Intrahippocampal 5-HT1A receptor antagonist inhibits the improving effect of low-frequency stimulation on memory impairment in kindled rats.

  2019cites this paper
• Neurosteroid dehydroepiandrosterone attenuates 6-hydroxydopamine-induced apoptosis in a cell model of Parkinson's disease

  2019cites this paper
• Nicotinic Mitigation of Neuroinflammation and Oxidative Stress After Chronic Sleep Deprivation

  2019cites this paper
• Neurosteroids as regulators of neuroinflammation.

  2019cites this paper
• Implication of nigral dopaminergic lesion and repeated L‐dopa exposure in neuropsychiatric symptoms of Parkinson's disease

  2019influential citation
• Early enriched environment prevents cognitive impairment in an animal model of schizophrenia induced by MK-801: Role of hippocampal BDNF.

  2019cites this paper
• Apelin-13 ameliorates cognitive impairments in 6-hydroxydopamine-induced substantia nigra lesion in rats.

  2018cites this paper
• Neuropathies induites par chimiothérapie néo-adjuvante du cancer du sein : atteintes périphériques et centrales, mécanismes impliqués et perspectives thérapeutiques

  2018cites this paper
• Structural Changes Observed in the Piriform Cortex in a Rat Model of Pre-motor Parkinson’s Disease

  2018cites this paper
• Translocator protein ligand, YL-IPA08, attenuates lipopolysaccharide-induced depression-like behavior by promoting neural regeneration

  2018cites this paper
• Ineffectiveness of saxagliptin as a neuroprotective drug in 6‐OHDA‐lesioned rats

  2018cites this paper
• Neurosteroid pregnenolone sulfate, alone, and as augmentation of lurasidone or tandospirone, rescues phencyclidine‐induced deficits in cognitive function and social interaction

  2018influential citation
• Salidroside Protection Against Oxidative Stress Injury Through the Wnt/β-Catenin Signaling Pathway in Rats with Parkinson’s Disease

  2018cites this paper
• EVALUACIÓN COMPORTAMENTAL DEL TRASPLANTE DE hMSC-GFP+ EN UN MODELO EXPERIMENTAL DE HEMIPARKINSON EN RATA WISTAR

  2017influential citation
• Neurosteroid allopregnanolone attenuates motor disability and prevents the changes of neurexin 1 and postsynaptic density protein 95 expression in the striatum of 6-OHDA-induced rats’ model of Parkinson’s disease

  2017cites this paper
• Effect of low frequency electrical stimulation on seizure-induced short- and long-term impairments in learning and memory in rats.

  2017cites this paper
• Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies.

  2017cites this paper
• Lentiviral-Mediated Overexpression of the 18 kDa Translocator Protein (TSPO) in the Hippocampal Dentate Gyrus Ameliorates LPS-Induced Cognitive Impairment in Mice

  2016cites this paper
• Estrogen and Progesterone Replacement Therapy Prevent Methamphetamine-Induced Synaptic Plasticity Impairment in Ovariectomized Rats

  2016cites this paper